Shopping Cart
- Remove All
- Your shopping cart is currently empty
Crisaborole (AN-2728) is a phosphodiesterase 4 inhibitor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | 36 € | In Stock | |
50 mg | 47 € | In Stock | |
100 mg | 78 € | In Stock | |
200 mg | 105 € | In Stock | |
1 mL x 10 mM (in DMSO) | 43 € | In Stock |
Description | Crisaborole (AN-2728) is a phosphodiesterase 4 inhibitor. |
Targets&IC50 | PDE4:0.49 μM |
In vitro | AN-2728 inhibits PDE isozymes PDE1A3, PDE3Cat , PDE4Cat and PDE7A1 with IC50 values of 6.1, 6.4, 0.11 and 0.73 μM. AN-2728 inhibits PDE4, TNF-α, IL-2, IFN-γ, IL-5 and IL-10 with IC50 values of 0.49, 0.54, 0.61, 0.83, 2.4 and 5.3 μM. AN-2728 shows the most potent activity against PDE4 catalytic domain, but it also shows inhibition against PDE1A3, PDE3Cat, and PDE7A1. Crystallography reveals that interaction of benzoxaboroles with the hydrophobic pocket in the PDE4 catalytic domain increase their affinity for PDE4. These benzoxaboroles strongly suppresses the secretion of cytokines associated with Ps and AD. |
In vivo | AN-2728 is well tolerated and significantly impacts efficacy markers, showing comparable results to positive controls in clinical trials. It effectively inhibits ear edema induced by phorbol ester with a dosing of 1 mg/ear×2 (78% and 68%, respectively), mirroring the efficacy of dexamethasone. This suggests AN-2728 possesses notable anti-inflammatory properties and skin penetration capabilities. |
Alias | PF-06930164, AN-2728 |
Molecular Weight | 251.05 |
Formula | C14H10BNO3 |
Cas No. | 906673-24-3 |
Smiles | OB1OCc2cc(Oc3ccc(cc3)C#N)ccc12 |
Relative Density. | 1.33 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (199.16 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.